The Compounding Pharmacy of America Recalls Recalls by year
A bar chart of the number of recalls naming this company by year.
Recalls by year
Year Recalls 2015 99 2018 1
Download CSV FDA Recall
Terminated
Historical record Class I
HCG 5,000 IU/mL + Methylcobalamin 500 mcg/mL Injection 5 mL, Multi-Dose Vial, Sterile, Rx Only, Compounded by The Compounding Pharmacy of America, 6216 Highland Place Way, Ste. 101A Knoxville, TN 37919 Ph (855) 277-2488 Fax (888) 689-9892 by The Compounding Pharmacy of America
Reason
Non-Sterility Published
February 21, 2018 Distribution
TN and SC
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix T-50/PGE 2/LIDO 2 0.09/0.32/0.04 Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix T-50/PGE 2/LIDO 2 0.03/0.18/0.09 Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix T-106 (30 mg/1 mg/25 mcg) Injectable,The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix T-102/PGE 2/LIDO 2 0.06/0.3/0.2 Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix T-101 (17.65 mg/0.59 mg/5.9 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix SUPER (28 mg/0.9 mg/37 mcg) Injectable, Sterile Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix ST9E (60 mg/4 mg/150 mcg) Injectable, Sterile Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix ST9C (30 mg/2 mg/120 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix ST9A (30 mg/2 mg/80 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix ST2 (30 mg/3 mg/100 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix ST1 (30 mg/1.5 mg/50 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
This page lists recalls that name The Compounding Pharmacy of America as the recalling firm in the official source notice. It is
not a safety rating, ranking, or statement that the company acted negligently.
Read the full medical disclaimer .
